Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
Endexx Corporation’s HYLA Division Partners With American Shaman, Expanding Distribution Across U.S. Locations
-
Scorpius Holdings Announces Partnership with U.S. Biotech Company
-
MeiraGTx Announces Five Posters at the European Society of Gene and Cell Therapy (ESGCT) 2024 Annual Congress
-
FuelCell Energy and KHNP to Pursue Clean Hydrogen Production Projects in Korea
-
Asset Entities Inc. is Pleased to Announce that it has Received an Extension from Nasdaq to Regain Compliance with Nasdaq Listing Rule 5550(b)
-
WillScot Announces Appointment of Worthing Jackman to Board of Directors
-
American Medical Association Approves Groundbreaking New CPT Codes for Totally Implantable Active Middle Ear Hearing Implants Opening New Opportunities for Envoy Medical’s Esteem® Device
-
ProPhase Labs to Present at the 2024 ThinkEquity Conference
-
Westwood Holdings Group, Inc. to Host Third Quarter 2024 Conference Call/Webcast
-
Menlo Micro Announces Global Distribution Agreement with DigiKey to Promote and Deliver Ideal Switch® Products
-
Cayson Acquisition Corp Announces Separate Trading of its Ordinary Shares and Rights
-
Recursion announces first patient dosed in Phase 2 clinical study of REC-3964, a potential first-in-class, oral, non-antibiotic small molecule for recurrent Clostridioides difficile infection
-
Annovis to Highlight Buntanetap's Alzheimer's Research Progress with Presentations at CTAD 2024
-
ARMLOGI ENHANCES WAREHOUSE OPERATIONS WITH AI-INTEGRATED WAREHOUSE MANAGEMENT SYSTEM
-
XOMA Royalty Significantly Expands its Royalty and Milestone Portfolio with the Addition of Over 60 Early-Stage Programs from Twist Bioscience
-
Gartner to Report Third Quarter 2024 Financial Results on November 5, 2024
-
Monopar Presents Encouraging Human Clinical Dosimetry Data on its uPAR Program at EANM 2024
-
Janover Unveils Janover Connect: A Reimagined Real Estate Syndication Platform
-
InnovAge to Announce Fiscal First Quarter 2025 Financial Results and Host Conference Call Tuesday, November 5, 2024
-
Gabelli Funds to Host 48th Annual Automotive Symposium at The Encore at Wynn, Las Vegas, Nevada
-
Indaptus Therapeutics Announces Clinical Supply Agreement with BeiGene to Evaluate Novel Cancer Treatment Combinations
-
PDS Biotech Announces Presentation of Rationale and Design of First Recurrent Prostate Cancer Trial to Combine an Androgen Receptor Pathway Inhibitor with an Immunocytokine
-
Huntress Recognized as Inc. 2024 Power Partner for Empowering Small and Mid-Sized Businesses with Cutting-Edge Cybersecurity Protection
-
Blade Air Mobility to Announce Third Quarter 2024 Financial Results on November 12, 2024
-
PodcastOne (PODC) Unveils Explosive 10th Season of The Opportunist: "Tim Ballard: Unmasking a Hero" - Exposing Dark Allegations
-
Guess What? Nobody and Everybody Cares About AI
-
Aligos Therapeutics Announces U.S. FDA Clearance of IND Application for ALG-000184
-
Nukkleus Announces Reverse Stock Split Shares Will Begin Trading on a Split-Adjusted Basis on October 24, 2024
-
Crunchtime Unveils AI Forecasting
-
Arteris to Announce Financial Results for the Third Quarter 2024 on Tuesday, November 5, 2024
-
Reminder: Program for the publication of Yara International ASA third quarter results 2024
-
Allarity Therapeutics to be Granted European Patent for DRP® Companion Diagnostic for Stenoparib
-
ThreatQuotient Unites Cybersecurity Leaders for a Week of In-Depth Threat Intelligence Exploration
-
Exo Therapeutics Announces Late Breaking Poster at American College of Rheumatology’s Convergence (ACR)
-
Waze Co-founder and former Infosys board member, Uri Levine, Returns to Zoomcar in Strategic Advisory Role
-
Guide Outdoor Releases the Powerhouse TS Gen2 Series Built for Hunting
-
Aurachain Unveils Advanced AI Features to Transform Organizations and Drive ROI
-
CLEAN EATZ CELEBRATES Q3 ACHIEVEMENTS AND FRANCHISEE SUCCESS AT 2024 ANNUAL CONVENTION
-
ZyVersa Therapeutics Highlights Published Data Demonstrating That Obesity Results in Neuroinflammation Implicated in Development of Neurodegenerative Diseases
-
ZyVersa Therapeutics Highlights Published Data Demonstrating That Obesity Results in Neuroinflammation Implicated in Development of Neurodegenerative Diseases
-
TRU Provides Update on Flagship Golden Rose Project
-
Quantum Biopharma (NASDAQ:QNTM) Posts Link on Its Website to Access the Filed Complaint Against CIBC World Markets, RBC Dominion Securities and Others, Seeking Damages in Excess of $700,000,000 USD, f
-
Form 8.3 - Learning Technologies Group plc - Octopus Investments
-
ProTek Devices' New Set of TVS Devices Deliver MIL-STD Grade Circuit Protection in Aircrafts
-
Syra Health To Discuss Third Quarter 2024 Financial Results
-
Blackbridge Investment Group (BIG) Announces Innovative Revenue-Based Financing Solution
-
SediVision Announces Newly Designed Website to Better Serve Wastewater Industry Professionals
-
Pasofino Gold Provides Update on Non-Brokered Private Placement
-
Autobrains Unveils Skills Product Line, Redefining Autonomous Driving With Scalable and Modular AI Solutions
-
Stillwater Critical Minerals to Present at the Emerging Growth Conference on October 30th
